A novel antibody-antigen based impedimetric immunosensor for low level detection of HER2 in serum samples of breast cancer patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-ionic liquid electrode

Analytica Chimica Acta

Volumn 874, Issue , 2015, Pages 66-74

  Arkan, Elham ^a   Saber, Reza ^b,c   Karimi, Ziba ^d   Shamsipur, Mojtaba ^e  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PAYAME NOOR UNIVERSITY   (Iran)

^e RAZI UNIVERSITY   (Iran)

Author keywords

Carbon ionic liquid electrode; Electrochemical impedance spectroscopy; Gold nanoparticles; HER2 antibody (Herceptin); Human epidermal growth factor receptor 2 (HER2) immunosensor; Multiwall carbon nanotubes

Indexed keywords

ANTIBODIES; ANTIGENS; CHARGE TRANSFER; CHEMICAL DETECTION; CYCLIC VOLTAMMETRY; DIAGNOSIS; DISEASES; ELECTROCHEMICAL ELECTRODES; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FIBER OPTIC SENSORS; GOLD METALLOGRAPHY; GOLD NANOPARTICLES; IMMUNOSENSORS; IONIC LIQUIDS; METAL NANOPARTICLES; NANOTUBES; SCREENING; SPECTROSCOPY;

ANTIGEN-ANTIBODY INTERACTION; CARBON IONIC LIQUID ELECTRODE; CHARGE TRANSFER RESISTANCE; HERCEPTIN; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2); IMPEDIMETRIC IMMUNOSENSORS; INTERFACIAL ELECTRON TRANSFER; SENSITIVITY AND SPECIFICITY;

MULTIWALLED CARBON NANOTUBES (MWCN);

1,6 HEXANEDITHIOL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GOLD NANOPARTICLE; MULTI WALLED NANOTUBE; REAGENT; TRASTUZUMAB; UNCLASSIFIED DRUG; 1,6-HEXANEDITHIOL; CARBON NANOTUBE; CROSS LINKING REAGENT; ERBB2 PROTEIN, HUMAN; GOLD; IMMOBILIZED ANTIBODY; IONIC LIQUID; METAL NANOPARTICLE; THIOL DERIVATIVE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BREAST CANCER; BREAST METASTASIS; CALIBRATION; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; ELECTROCHEMICAL DETECTION; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTRON TRANSPORT; EQUIPMENT DESIGN; HUMAN; IMMOBILIZATION; IMMUNOSENSOR; INCUBATION TIME; ION SELECTIVE ELECTRODE; IONIC LIQUID ELECTRODE; LIMIT OF DETECTION; LINEAR SYSTEM; PH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS; TEMPERATURE; VALIDATION STUDY; BLOOD; BREAST TUMOR; CHEMISTRY; DEVICES; ELECTRODE; FEMALE; GENETIC PROCEDURES; IMMUNOASSAY;

ANTIBODIES, IMMOBILIZED; BIOSENSING TECHNIQUES; BREAST NEOPLASMS; CROSS-LINKING REAGENTS; DIELECTRIC SPECTROSCOPY; ELECTRODES; FEMALE; GOLD; HUMANS; IMMUNOASSAY; IONIC LIQUIDS; LIMIT OF DETECTION; METAL NANOPARTICLES; NANOTUBES, CARBON; RECEPTOR, ERBB-2; SULFHYDRYL COMPOUNDS;

EID: 84928214041     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.03.022     Document Type: Article

References (42)

1. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., Radich J., Anderson G., Hartwell L. Early detection: the case for early detection. Nat. Rev. Cancer 2003, 3:243-252.
2. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., Mills G.B., Simone C., Fishman D.A., Kohn E.C., Liotta L.A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-577.
3. Kawakami J., Siemens D.R., Nickel J.C. Prostatitis and prostate cancer: implications for prostate cancer screening. Urology 2004, 64:1075-1080.
4. Tse C., Brault D., Gligorov J., Antoine M., Neumann R., Lotz J.-P. Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients, Capeau. Clin. Chem. 2005, 51:1093-1101.
5. Payne R.C., Allard J.W., Anderson-Mauser L., Humphreys J.D., Tenney D.Y., Morris D.L. Automated assay for HER-2/neu in serum. Clin. Chem. 2000, 46:175-182.
6. Esteva F.J., Cheli C.D., Fritsche H., Fornier M., Slamon D., Thiel R.P., Luftner D., Ghani F. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies. Breast Cancer Res. 2005, 7:R436-R443.
7. Ludovini V., Gori S., Colozza M., Pistola L., Rulli E., Floriani I., Pacifico E., Tofanetti F., Sidoni A., Basurto C. Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival. Ann. Oncol. 2008, 19:883-890.
8. Leyland-Jones B., Smith B.R. Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls. Lancet Oncol. 2011, 12:286-295.
9. Moelans C., de Weger R., Van der Wall E., van Diest P. Current technologies for HER2 testing in breast cancer. Crit. Rev. Oncol./Hematol. 2011, 80:380-392.
10. Gohring J.T., Dale P.S., Fan X. Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor. Sens. Actuators B 2010, 146:226-230.
11. Lottner C., Schwarz S., Diermeier S., Hartmann A., Knuechel R., Hofstaedter F., Brockhoff G. Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer. J. Pathol. 2005, 205:577-584.
12. Streckfus C., Bigler L., Dellinger T., Dai X., Kingman A., Thigpen J.T. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin. Cancer Res. 2000, 6:2363-2370.
13. McNaught A.D., Wilkinson A. Compendium of Chemical Terminology 1997, vol. 1669. Blackwell Science, Oxford.
14. Bally M., Halter M., Vörös J., Grandin H.M. Optical microarray biosensing techniques. Surf. Interface Anal. 2006, 38:1442-1458.
15. Kosa C., Kardos L., Kovacs J., Szollosi Z. Comparison of dual-color dual-hapten brightfield in situ hybridization (DDISH) and fluorescence in situ hybridization in breast cancer HER2 assessment. Pathol. Res. Prac. 2013, 209:147-150.
16. Chen C., Xia H.-S., Gong Y.-P., Peng J., Peng C.-W., Hu M.-B., Zhu X.-B., Pang D.-W., Sun S.-R., Li Y. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials 2010, 31:8818-8825.
17. Lucarelli F., Tombelli S., Minunni M., Marrazza G., Mascini M. Electrochemical and piezoelectric DNA biosensors for hybridisation detection. Anal. Chim. Acta 2008, 609:139-159.
18. Capobianco J.A., Shih W.Y., Adams G.P., Shih W.-H. Label-free Her2 detection and dissociation constant assessment in diluted human serum using a longitudinal extension mode of a piezoelectric microcantilever sensor. Sens. Actuators B 2011, 160:349-356.
19. Wang J. Biosens. Bioelectron. 2006, 21:1887-1892.
20. Mucelli S.P., Zamuner M., Tormen M., Stanta G., Ugo P. Nanoelectrode ensembles as recognition platform for electrochemical immunosensors. Biosens. Bioelectron. 2008, 23:1900-1903.
21. Al-Khafaji Q.A.M., Harris M., Tombelli S., Laschi S., Turner A.P.F., Mascini M., Marrazza G. An electrochemical immunoassay for HER2 detection. Electroanalysis 2012, 24:735-742.
22. Zhu Y., Chandra P., Shim Y. Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-Au nanoparticle-aptamer bioconjugate. Anal. Chem. 2013, 85:1058-1064.
23. Chun L., Kim S.-E., Cho M., Choe W.-S., Nam J., Lee D.W., Lee Y. Electrochemical detection of HER2 using single stranded DNA aptamer modified gold nanoparticles electrode. Sens. Actuators B 2013, 186:446-450.
24. Emami M., Shamsipur M., Saber R., Irajirad R. An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2-iron oxide nanoparticle bioconjugates. Analyst 2014, 139:2858-2866.
25. Patris S., De Pauw P., Vandeput M., Huet J., Van Antwerpen P., Muyldermans S., Kauffmann J.-M. Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination. Talanta 2014, 130:164-170.
26. Gohring J.T., Dale P.S., Fan X. Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor. Sens. Actuators B Chem. 2010, 146:226-230.
27. Yan M., Sun G., Liu F., Lu J., Yu J., Song X. An aptasensor for sensitive detection of human breast cancer cells by using porous GO/Au composites and porous PtFe alloy as effective sensing platform and signal amplification labels. Anal. Chim. Acta 2013, 798:33-39.
28. Orazem M.E., Tribollet B. Electrochemical Impedance Spectroscopy 2011, 48. Wiley.
29. Pejcic B., De Marco R. Electrochemical detection of HER2 using single stranded DNA aptamer modified gold nanoparticles electrode. Electrochim. Acta 2006, 51:6217-6229.
30. Liu Y., Yin F., Long Y., Zhang Z., Yao S. Study of the immobilization of alcohol dehydrogenase on Au-colloid modified gold electrode by piezoelectric quartz crystal sensor, cyclic voltammetry, and electrochemical impedance techniques. J. Colloid Interface Sci. 2003, 258:75-81.
31. Behzad M., Asgari M., Shamsipur M. Impedimetric and stripping voltammetric detection of sub-nanomolar amounts of mercury at a gold nanoparticle modified glassy carbon electrode. J. Electrochem. Soc. 2013, 160:B31-B36.
32. Shamsipur M., Kazemi S.H., Mousavi M.F. Impedance studies of a nano-structured conducting polymer and its application to the design of reliable scaffolds for impedimetric biosensors. Biosens. Bioelectron. 2008, 24:104-110.
33. Shamsipur M., Asgari M., Ghannadi Maragheh M., Moosavi-Movahedi A.A. A novel impedimetric nanobiosensor for low level determination of hydrogen peroxide based on biocatalysis of catalase. Bioelectrochemistry 2012, 83:31-37.
34. Shamsipur M., Asgari M., Mousavi M.F., Davarkhah R. A novel hydrogen peroxide sensor based on the direct electron transfer of catalase immobilized on nano-sized NiO/MWCNTs composite film. Electroanalysis 2012, 24:357-367.
35. Arkan E., Saber R., Karimi Z., Mostafaie A., Shamsipur M. Multiwall carbon nanotube-ionic liquid electrode modified with gold nanoparticles as a base for preparation of a novel impedimetric immunosensor for low level detection of human serum albumin in biological fluids. J. Pharmaceut. Biomed. Anal. 2014, 92:74-81.
36. Safavi A., Maleki N., Moradlou O., Tajabadi F. Simultaneous determination of dopamine, ascorbic acid, and uric acid using carbon ionic liquid electrode. Anal. Biochem. 2006, 359:224-229.
37. Maleki N., Safavi A., Farjami E., Tajabadi F. Palladium nanoparticle decorated carbon ionic liquid electrode for highly efficient electrocatalytic oxidation and determination of hydrazine. Anal. Chim. Acta 2008, 611:151-155.
38. Opallo M., Lesniewski A. A review on electrodes modified with ionic liquids. J. Electroanal. Chem. 2011, 656:2-16.
39. Lu M., Li X., Yu B., Li H. Electrochemical behavior of Au colloidal electrode through layer-by-layer self-assembly. J. Colloid Interface Sci. 2002, 248:376-382.
40. Slot J.W., Geuze H.J. A new method of preparing gold probes for multiple-labeling cytochemistry. Eur. J. Cell. Biol. 1985, 38:87-93.
41. Masereel B., Dinguizli M., Bouzin C., Moniotte N., Feron O., Gallez B., Borght T.V., Michiels C., Lucas S. Antibody immobilization on gold nanoparticles coated layer-by-layer with polyelectrolytes. J. Nanopart. Res. 2011, 13:1573-1580.
42. Nahta R., Esteva F.J. Herceptin: mechanisms of action and resistance. Cancer Lett. 2006, 232:123-138.